Moreover, curcumin could inhibit STAT3 in cancer cells and DCs for promoting the antitumor T cell responses, which reversed the immunosuppression in tumor microenvironment and showed a synergistic antitumor effect with the treatment of anti-PD-1/PD-L1 antibodies 222. This evidence concerns the gene STAT3 and neoplasm.